Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

9966.HK Gross Margin

The Gross Margin of Alphamab Oncology (9966.HK) is 90.58%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

9966.HK Gross Margin - Historical Value
Date Value
2024-12-31 90.58%
2023-12-31 74.75%
2022-12-31 73.50%
2021-12-31 97.93%
2020-12-31 97.93%
9966.HK Gross Margin - Peers Comparison